Speakers

Jennifer Chow

Chief Executive Officer & Managing Director • Chimeric Therapeutics

Jennifer Chow is the Chief Executive Officer and Managing Director of Chimeric Therapeutics. Jennifer is a cell therapy pioneer and expert with experience developing and commercializing FDA approved CAR T cell therapies, Abecma™, Breyzani™, Yescarta™ and Tecartus™. Jennifer also has experience leading the commercial development for more than 15 pipeline cell therapies.

Jennifer joined Chimeric from Kite Pharmaceuticals where she was the Head of Global Marketing, Analytics and Commercial Operations and was responsible for optimizing the commercial development of all Kite pipeline therapies.

Prior to Kite, Jennifer was the Global Cell Therapy Commercial Lead at Celgene Corporation defining the global commercial strategy and operating model for Celgene cell therapies.

Jennifer has developed over 10 oncology therapeutics for launch and has more than 20 years’ experience in the biotech and pharmaceutical field.

Also Speaking

Xavier De Mollerat Du Jeu

Senior Director of Research and Development • Thermo Fisher Scientific Inc

Andrés Bratt-Leal

Co-Founder, Senior Vice President, Research and Development • Aspen Neuroscience

Eytan Abraham

Vice President & Business Head, Cell Therapy, Gene Therapy • Nucleic Acids

Also Speaking

Image

Post-Event Report

Download the post-event report for Advanced Therapies Week 2024.
Image

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.